Recognizing & Managing Clozaril Toxicity: How Much is Too Much?

Clozaril (clozapine) has the potential to cause a number of toxic effects, especially at high doses. Symptoms of Clozaril toxicity include:

  • Sedation and drowsiness: Excessive sedation is a sign of elevated Clozaril levels and risk of toxicity. Patients may seem overly lethargic, drowsy or even in a stupor. Dose reduction usually reverses this effect.
  • Dizziness or confusion: Feeling lightheaded, unsteady or confused can indicate toxicity and require medical review. May lead to falls if severe.
  • Tachycardia: A rapid heart rate, often above 120 beats per minute. Can usually be managed by temporarily withholding Clozaril and may necessitate dose reduction or beta-blockers.
  • Hypersalivation: Although common even within the therapeutic range, excessive salivation may be a symptom of toxicity in some patients, especially if of sudden onset or severity. Anticholinergics can provide relief but toxicity may still need to be addressed.
  • Nausea or diarrhea: Sometimes transient, but can be severe in toxicity and lead to dehydration or electrolyte imbalance if prolonged. May require IV fluids or hospitalization.
  • Agitation or delirium: Although less likely at higher doses, some patients may become increasingly agitated, restless, irritable or even delirious when Clozaril levels are too high. Often resolves within 24-48 hours of stopping Clozaril.
  • Seizures: Clozaril lowers the seizure threshold and at very high levels seizures become more likely, especially in susceptible individuals or if combined with other seizure risk factors. Requires immediate medical help and discontinuation of Clozaril.
  • Neuroleptic malignant syndrome: A rare but life-threatening reaction seen with excessive dopaminergic blockade. Manifests as severe rigidity, fever, delirium and autonomic instability. Discontinue Clozaril and other antipsychotics immediately. IV fluids and medications may be needed to manage symptoms.
  • Loss of consciousness: High Clozaril levels that produce stupor, confusion or delirium can progress to a loss of consciousness in some cases. Patients will require hospitalization for close monitoring and supportive management until drug levels decrease and symptoms improve.
  • Other effects: Constipation, changes in blood pressure or temperature, blurred vision, tremor or headache may also indicate toxicity for some individuals. Seek medical review, especially if multiple symptoms are present or a sudden change from baseline.

In summary, symptoms of Clozaril toxicity span sedation through to potential loss of consciousness in severe cases. However, not all patients will demonstrate the full range or same number of symptoms. Close monitoring, especially when changing doses or if side effects seem disproportionate, is key to early detection and intervention to limit risks. Prompt review and, where indicated, temporary cessation or reduction of Clozaril will usually reverse symptoms and prevent progression, although some may require hospital support until stabilized. Ongoing vigilance and individual risk management remain essential due to inter-patient variability in sensitivity and manifestations of toxicity.


There are various forms of drugs available, such as tablets or liquids, and each may have a separate patient information leaflet (PIL) for different doses. It is important to refer to the PIL for the specific form and dose of the drug that you have been prescribed.

You can search for further information and PILs on websites such as:

  • The British National Formulary (BNF)
  • Electronic medicines compendium (emc)
  • The National Library of Medicine's DailyMed
  • The Food and Drug Administration (FDA) 
  • Different drug forms like tablets or liquids have specific patient information leaflets (PIL) for various doses. Refer to the PIL for your prescribed drug form and dose.

    Search for PILs on websites like:

    France

    • ANSM (Agence nationale de sécurité du médicament et des produits de santé): ansm.sante.fr

    Spain

    • AEMPS (Agencia Española de Medicamentos y Productos Sanitarios): aemps.gob.es

    Germany

    • BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte): bfarm.de

    Italy

    For questions about your medication:

    • Consult your doctor, a healthcare professional, or a pharmacist

    France

    • Contact SOS Médecins: 3624
    • For mental health support, contact SOS Suicide: 01 45 39 40 00

    Belgium (French)

    Switzerland (French)

    • La Main Tendue: 143
    • Website: 143.ch

    Canada (French)

    • Centre de prévention du suicide du Québec: 1 866 APPELLE (1 866 277-3553)
    • Website: cpsquebec.ca

    Spain

    • Contact emergency number: 112
    • For mental health support, contact Teléfono de la Esperanza: 717 003 717

    Germany

    • Contact emergency number: 112
    • For mental health support, contact Telefonseelsorge: 0800 111 0 111 or 0800 111 0 222

    Italy

    • Contact emergency number: 112
    • For mental health support, contact Telefono Amico: 199 284 284

    Netherlands

    • Contact emergency number: 112
    • For mental health support, contact 113 Zelfmoordpreventie: 0800 0113

    Portugal

    • Contact emergency number: 112
    • For mental health support, contact Sos Voz Amiga: 21 354 45 45, 91 280 26 69, or 96 352 46 60

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.